If you're feeling unwell, get tested for COVID-19 and stay home until you’ve received a negative result. View our latest COVID-19 updates.
Monash BDI Global Change Program.
Discover what sets us apart
Research reveals a vaccine platform that could tackle a multitude of diseases.
The Monash Biomedicine Discovery Institute (BDI) is changing the rules in the fight against disease, embracing new perspectives for new solutions. We're part of the Faculty of Medicine, Nursing and Health Sciences.
Home to more than 700 researchers, 120 research groups and 200 international research collaborators, we're one of the largest – and highest quality – research institutes in the southern hemisphere.
With a growing pipeline of biomedical breakthroughs – such as our work with stem cells and immunology – we're accelerating discoveries in the lab into clinical treatments.
Hone your expertise under the guidance of at least two supervisors. Join our growing network of more than 270 PhD students across 100 labs, focused on making novel scientific discoveries.
We're committed to making the discoveries that will relieve the future burden of disease. But we need your help.
Our more than 120 specialised research labs are led by recognised leaders in the biomedical field.
We're making the research discoveries that tackle global health issues.
Humanity continues to face challenges in the fight against disease. Watch our two-minute video to discover what we're doing about it.
Want to research, invest, study, or partner with us? We’d love to hear from you.
Monash BDI general enquiries
T: +61 3 9902 9400
23 Innovation Walk
Clayton, Victoria, 3800
Join the conversation
Be inspired by hearing about the latest biomedical research from scientists at the top of their field. Free and open to all to attend.
Professor Jamie Rossjohn, one of Australia’s leading scientists, has been elected as a Fellow of the Royal Society (FRS) - one of the world’s most prestigious scientific bodies - in recognition of his transformative contributions to science.
A new paper led by Monash researchers describes the exciting ‘concept-to-clinical-trial’ journey of QPX9003, a much-needed novel antibiotic targeting drug-resistant Gram-negative ‘superbugs’.
Influenza, commonly referred to as “flu”, is a major global public health concern and a huge economic burden to societies.
Last week on Monash University’s What Happens Next? podcast, the show’s guest experts served up some unappetising truths about weight loss. Ultimately, our body types are not necessarily dictated by the foods we eat or the amount of exercise we do.
An engaged audience at Monash University heard CEO and Director of Cold Spring Harbor Laboratory in the US, Professor Bruce Stillman, AO, speak of the wide-ranging impacts of investing in fundamental discovery research, give insights into career success and predict some exciting directions of biomedical science in the future.